ClinicalTrials.govpublic full text
Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia
adult acute myeloid leukemia with t(15;17)(q22;q12), adult acute promyelocytic leukemia (m3), myelodysplastic syndromes, myelodysplastic/myeloproliferative neoplasms, recurrent adult acute myeloid leukemia, secondary acute myeloid leukemia, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873797
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.